What is it about?
As a physiological state, the first recommended option for menopausal symptoms is a natural and healthy therapy, alone or in combination with pharmacotherapy in severe cases. Among other natural alternatives, E-MHK-0103, a nutraceutical lipoprotein extracted from Mytilus galloprovincialis, was found to have beneficial properties. The findings of this review confirm the efficiency of natural therapies in menopause symptoms, and E-MHK- 0103 as a healthy choice for inclusion into clinical practice.
Featured Image
Why is it important?
The findings of this review confirm the efficiency of natural therapies in menopause symptoms, and EMHK- 0103 (Mineraxin) as a healthy choice for inclusion into clinical practice.
Perspectives
The use of the natural therapies in the treatment of different diseases is increasing. This review shows the current natural and pharmacological therapies for the relief of menopausal symptoms. We highlight the efficiency of nutraceuticals as E-MHK-0103 (Mineraxin) with important health benefits without adverse reactions. We truly believe that Mineraxin could be an effective alternative in clinical practice, alone or in combination with pharmacotherapy in severe cases.
LOLA CORZO
Euroespes Biomedical Research Center
Read the Original
This page is a summary of: E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal Conditions, Current Drug Metabolism, January 2017, Bentham Science Publishers,
DOI: 10.2174/1389200217666161014151341.
You can read the full text:
Contributors
The following have contributed to this page
